Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Drug News & Perspectives|January 8, 2008
Emerging therapies for respiratory diseasesRuth Lock, Steve Collingwood, Andrew RatcliffeJournal of Clinical Pharmacology|March 7, 2022
The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK-954)Richard Czerniak, Blanka Cieslarová, Viera Kupčová, et al.Clinical Pharmacology in Drug Development|January 6, 2022
Evaluation of the Pharmacokinetics of Felcisetrag (TAK-954), a 5-HT4 Receptor Agonist, in the Presence and Absence of Itraconazole, a Potent CYP3A4 InhibitorChunlin Chen, Liming Zhang, Cristina Almansa, et al.European Journal of Drug Metabolism and Pharmacokinetics|December 24, 2024
Mass Balance Recovery, Absorption, Metabolism, and Excretion of Elinzanetant in Healthy Human Volunteers and in vitro BiotransformationSimone I Schulz, Marcus-Hillert Schultze-Mosgau, Anna Engelen, et al.Chest|February 16, 2013
Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosisSteven M Rowe, Ginger Reeves, Heather Hathorne, et al.Advanced Drug Delivery Reviews|December 15, 2010
Challenges in inhaled product development and opportunities for open innovationBen Forbes, Bahman Asgharian, Lea Ann Dailey, et al.Pageof 1